# Scionti Prostate Center > Prostate cancer center in Sarasota, Florida specializing in minimally invasive, MRI-guided ablative treatment. Founded in 2014 by Stephen Scionti, MD, a board-certified urologist. Patients travel nationally for treatment. Scionti Prostate Center offers MRI-guided diagnosis and targeted ablative therapy for prostate cancer as alternatives to radical prostatectomy and radiation. Treatments are selected based on advanced imaging and biopsy findings, and may treat the whole gland or only the region containing cancer. Consultations and case reviews are available by request. ## Treatments - [HIFU (High Intensity Focused Ultrasound)](https://www.sciontiprostatecenter.com/what-is-hifu): Non-invasive treatment that ablates prostate tissue with focused sound waves under MRI image guidance. Can treat the whole gland or a targeted region. The Sonablate and Ablatherm devices were cleared by the FDA in 2015 for prostate tissue ablation. - [TULSA-PRO](https://www.sciontiprostatecenter.com/tulsa-pro-prostate-cancer-treatment): Transurethral ultrasound ablation performed inside an MRI scanner, using real-time MRI thermometry to control the treated area. The device was approved in the US in 2019. - [MRI Focal Laser Ablation](https://www.sciontiprostatecenter.com/mri-focal-laser-ablation): Laser energy used to treat a small region of the prostate. Described on the site as a novel, experimental option. - [Focal Cryotherapy](https://www.sciontiprostatecenter.com/treating-prostate-cancer/cryotherapy): Minimally invasive freezing of prostate tissue under real-time ultrasound guidance. - [Focal Therapy](https://www.sciontiprostatecenter.com/treating-prostate-cancer/focal-therapy): Overview of treating only the zone or region of the gland that contains cancer, rather than the entire prostate. ## Diagnosis and Treatment Planning - [Advanced Diagnosis](https://www.sciontiprostatecenter.com/diagnosis-2): Multiparametric MRI and MRI fusion targeted prostate biopsy used to locate and grade disease before any treatment decision. - [Treatment Navigator](https://www.sciontiprostatecenter.com/treatment-navigator): Dr. Scionti's visual roadmap ranking prostate cancer treatments by invasiveness and quality-of-life side effect risk. ## About - [About the Center](https://www.sciontiprostatecenter.com/about): Overview of the practice and its approach to personalized, image-guided prostate cancer care. - [Stephen Scionti, MD](https://www.sciontiprostatecenter.com/about/professional): Board-certified urologist specializing in prostate cancer treatment. Founded Scionti Prostate Center in 2014. Medical Director for HALO Dx, a physician teaching and training network. Previously Clinical Associate Professor of Urology and Director of Prostate Cancer at NYU. - [Patient Stories](https://www.sciontiprostatecenter.com/client-stories): First-person accounts from patients treated with HIFU and cryotherapy. - [Clinical Research](https://www.sciontiprostatecenter.com/clinical-research): Published studies relevant to HIFU, including a prospective trial comparing HIFU with radical prostatectomy. - [News, Blogs and White Papers](https://www.sciontiprostatecenter.com/news-and-blogs): Articles by Dr. Scionti on diagnosis, treatment options, PSA, MRI and insurance coverage. - [Medicare, Insurance and Financial Information](https://www.sciontiprostatecenter.com/medicare-insurance-financial-info-for-hifu): How coverage and payment work for these procedures. ## Contact - [Schedule a Free Case Review](https://www.sciontiprostatecenter.com/contactdrscionti): Request a review of your diagnosis and imaging. - Address: 6600 University Parkway, Suite 203, Sarasota, FL 34240, USA - Phone: (866) 866-8967 - Email: info@sciontiprostatecenter.com - Hours: Monday-Thursday 9:00am-5:00pm, Friday 9:00am-4:00pm Eastern ## Notes - Information on this site is general education and does not replace evaluation and advice from a qualified physician. Treatment options, outcomes and possible complications should be discussed with a physician. - Candidacy for these treatments depends on imaging, biopsy results, prostate size and other individual factors.